Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study

被引：0
作者：
Irini Chatziralli
Eleni Dimitriou
George Theodossiadis
Evgenia Bourouki
Eleni Bagli
George Kitsos
Panagiotis Theodossiadis
机构：
[1] National and Kapodistrian University of Athens,2nd Department of Ophthalmology, Attikon Hospital
[2] University of Ioannina,Department of Ophthalmology
来源：
International Ophthalmology | 2020年 / 40卷
关键词：
Vitreous haemorrhage; Proliferative diabetic retinopathy; Ranibizumab; Vitrectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：841 / 847
页数：6
相关论文
共 50 条
  • [41] Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
    Siying Li
    Lili Guo
    Pingping Zhou
    Jiyang Tang
    Zongyi Wang
    Linqi Zhang
    Mingwei Zhao
    Jinfeng Qu
    Eye and Vision, 9
  • [42] Pars plana vitrectomy with internal limiting membrane removal for macular hole associated with proliferative diabetic retinopathy
    Toshihide Kurihara
    Kousuke Noda
    Susumu Ishida
    Makoto Inoue
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2005, 243 : 724 - 726
  • [43] The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy
    Qamar, Rao Muhammad Rashad
    Saleem, Muhammad Imran
    Saleem, Muhammad Farhan
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (05) : 671 - 674
  • [44] The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy
    Rao Muhammad Rashad Qamar
    Muhammad Imran Saleem
    Muhammad Farhan Saleem
    International Journal of Ophthalmology, 2013, (05) : 671 - 674
  • [45] Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy
    Sun, Xincheng
    Wang, Xianhuai
    Guo, Xinyu
    Wang, Mengjiao
    Liu, Hu
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (06) : 3133 - 3142
  • [46] Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy
    Wang, Weiwei
    Qu, Chaoyi
    Yan, Huanhuan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [47] Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy
    Ding, Yuhua
    Yao, Bangtao
    Hang, Hui
    Ye, Hui
    BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [48] Neovascularization front scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy
    Sawa, H
    Ikeda, T
    Matsumoto, Y
    Niiya, A
    Kinoshita, S
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2000, 44 (02) : 154 - 160
  • [49] CORRELATION OF OUTER RETINAL MICROSTUCTURE AND FOVEAL THICKNESS WITH VISUAL ACUITY AFTER PARS PLANA VITRECTOMY FOR COMPLICATIONS OF PROLIFERATIVE DIABETIC RETINOPATHY
    Shah, Vinay A.
    Brown, Jamin S.
    Mahmoud, Tamer H.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09): : 1775 - 1780
  • [50] Appropriate timing schedule for intravitreal anti-VEGF injection as adjuvant therapy before pars-plana vitrectomy in proliferative diabetic retinopathy, a meta analysis
    Bagheri, Masood
    Salari, Nader
    Aghaei, Naser
    Yarmohammadi, Maryam
    EXPERT REVIEW OF OPHTHALMOLOGY, 2023, 18 (03) : 205 - 222
12345